The preparation of anticancer chemotherapy in a hospital must meet several objectives; the first main is the quality, which can be provided by setting up a surveillance system and a quality control of each preparations. The aim of this work is to present a simple, fast and accurate spectrophotometric method for the routine control of cytotoxic preparations.
Materials and methods
This is a study carried out in the cytotoxic preparation unit of the university center of Rabat-Sale children’s hospital in Morocco. All samples of preparations were collected and analyzed daily on the site. After validation of the analytical method with respect to many parameters such as: linearity, accuracy and precision according to ICH Q2 guidelines, samples of cytotoxic preparations collected were assayed.
Results
The results are satisfactory with good level of exactitude, and high precision.
Conclusion
Compared to other techniques, this method can be considered as a useful alternative in the routine quality control of preparations. It can quickly obtain qualitative and quantitative information with instrumentation and inexpensive reagents.
FerlayJShinHRBrayF, et al.
GLOBOCAN 2008. Int J Cancer2010;
127: 2893–2917.
2.
GallelliJF.Issues and risks associated with antineoplastic drugs. J Pharm Pract1991;
4: 72–76.
3.
LegatCLimatSCoutetJ, et al.
Economic impact of the centralized preparation of anticancer drugs. J Clin Pharm2003;
22: 181–185.
4.
RochereauFKaluzinskiLBannieF.Centralized preparation of chemotherapy IV: do we fully control the risk for safe patient care?Hospital Pharm Clin2012;
47: 269.
5.
ASoH-S Pharmacists.
ASHP guidelines on quality insurance for pharmacy-prepared sterile products. American Society of Health System Pharmacists. Am J Health Syst Pharm2000;
57: 1150–1169.
6.
LimatSMadroszyk-FlandinANalletG, et al.
Iatrogenic risk related to the preparation of anticancer drugs. Oncol J2002;
4: 203–208.
7.
BasuyauFBrunelleP.Comparison of two rapid physical measurements for dose control of injectable anticancer drugs before administration: application to 5-fluorouracil. J Clin Pharm2000;
19: 5–9.
8.
HavardLBonanBHuenJ, et al.
Centralized quality control of cytotoxic reconstitution: myth or reality?STP Pharm Pract2005;
15: 148–160.
9.
BonanBMartelliNBerhouneM, et al.
The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs.Int J Qual Health Care2008;
21: 44–50.
10.
WattSAntierDJacquesV, et al.
New program for quality control of cytotoxics manufactured in centralized unit. J Clin Pharm2002;
21: 179–182.
11.
LimatSDrouhinJDemesmayK, et al.
Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit. Pharm World Sci2001;
23: 102–106.
12.
Savelli M, Roche M, CURTI C, et al. Methods to control anticancer chemotherapy preparations ranked by risk analysis. Die Pharmazie-An Int J Pharml Sci 2018; 73(5): 251–259.
13.
PelusEDellanegraMCharletyD, et al.
Central cytotoxic preparation unit: from set-up to quality assurance. J Clin Pharm1998;
17: 97–102.
14.
RipocheNBaumgartnerPAudevalC, et al.
Feasibility study of extemporaneous control of cytotoxic preparations: tests with an innovative UV/visible spectroscopic coupling and IR detections. EJHP Pract2009;
15: 28–31.
15.
RoweECSavageSWRutalaWA, et al.
Economic and microbiological evaluation of single-dose vial extension for hazardous drugs.J Oncol Pract2012;
8: e45–E49.
16.
DelmasAGordienJBernadouJ, et al.
Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparation unit. J Pharm Biomed Anal2009;
49: 1213–1220.
17.
BazinCVieillardVAstierA, et al.
Fast and reliable control of monoclonal antibody chemotherapy preparations using the Multispec® PLC. French Pharm Ann2010;
68: 163–177.
18.
SiddappaKPrashantCSunilkumar ManeB, et al.
Development and validation of spectrophotometric method for the determination of cyclophosphamide in bulk drug and its pharmaceutical dosage form. Int J Pharm Pharm Sci2014;
5: 597–600.
19.
Jeewantha A, Ivanovich A and Mihailovich KP. Validated spectrophotometric method for the estimation of vincristine and vinblastine. Int J Pharm Pharm Sci 2017; 9: 78–86.
20.
Reddy C and Reddy G. Validated method for vinblastine by spectrophotometry in bulk drug and pharmaceutical formulations. J Chem Pharm Res 2012; 4: 3703–3707.
21.
AnabellaN.Stability of anticancer drugs after reconstitution, physicochemical incompatibilities and antimicrobial activity. Rabat, Morocco: Faculty of Medicine and Pharmacy – Mohammed V Rabat University, 2017.
22.
GUIDELINE, ICH Harmonised Tripartite. Validation of analytical procedures: text and methodology Q2 (R1). In: International conference on harmonization, Geneva, Switzerland, 2005, pp.11–12.
23.
DelisBWinemakerJSobalakN, et al.
Analytical control of cytotoxic preparations: a review of 7 years of activity and prospects.Hospital Pharm Clin2015;
50: 233–242.
24.
BourgetPAminAVidalF, et al.
Comparison of Raman spectroscopy vs. high performance liquid chromatography for the control of complex therapeutics: model of elastomeric portable pumps filled with a fluorouracil solution.J Pharm Biomed Anal2014;
91: 176–184.
25.
BourgetPAminAMoriceauA, et al.
Raman spectroscopy (SR): a new tool adapted to the analytical quality control of injectable preparations in healthcare settings. Comparison of SR with HPLC and UV/Visible-IRTF techniques applied to the class of anthracyclines in oncology. Pathol Biol2012;
60: 369–379.
26.
LeLMMCaudronEBaillet-GuffroyAEveleighL.Non-invasive quantification of 5 fluorouracil and gemcitabine in aqueous matrix by direct measurement through glass vials using near-infrared spectroscopy.Talanta2014;
119: 361–366.
27.
Carrez L, Bouchoud L, Fleury-souverain S, et al. Reliability of chemotherapy preparation processes: evaluating independent double-checking and computer-assisted gravimetric control. J Oncol Pharm Pract 2017; 23: 83–92.
28.
GaëlleLR. Feasibility study of the installation of a digital video control for anti-cancer preparations within the pharmacy for indoor use of the UFR Toulouse University Cancer Institute, Pharmaceutical Sciences, University of Bordeaux, 2016.
29.
OsmanNEdetSPadoinC, et al.
Adaptation of a round of dose within a unit of preparation of chemotherapy: a real interest. Hosp Pharm Clin2013;
48: 270–271.
30.
ChatelutEWhite-KoningMMathijssenRH, et al.
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.Br J Cancer2012;
107: 1100.
31.
Guidance for industry: PAT-A framework for innovative pharmaceutical development, manufacturing, and quality assurance. DHHS, Rockville, MD, 2004.
32.
Siddappa K, Prashant C, Sunilkumar Mane B, et al. Development and validation of spectrophotometric method for the determination of cyclophosphamide in bulk drug and its pharmaceutical dosage form. Int J Pharm Pharm Sci 2013; 5; 597–600.
33.
HuangLSuiWWangY, et al.
Preparation of chitosan/chondroitin sulfate complex microcapsules and application in controlled release of 5-fluorouracil. Carbohyd Polym2010;
80: 168–173.
34.
JobardMLepageCSejeanK, et al.
Validation of the dosage of bendamustine preparations by the Multispec® PLC.Hosp Pharm Clin2013;
48: 258.
35.
CamutANoirVKhalifeA, et al.
Creation of a personalized training tool for the technique of analytical control of preparations by the Multispec® spectrometer and validation by ten pharmaceutical user teams.Hosp Pharm Clin2011;
46: 245–255.
36.
ChouquetTBenoitGMorandK.Implementation of analytical control of low volume pediatric cytotoxic drugs preparations using a UV/Raman spectrophotometer. Pharm Technol Hosp Pharm2016;
1: 151–162.
37.
BazinCVieillardVAstierA, et al.
Implementation of real-time identification analysis and quantification of chemotherapies preparations with a Multispec® analyzer.French Pharm Ann2014;
72: 33–40.
38.
ParentGPerrinSBichardD, et al.
Impact of a double audit of practices within a unit of clinical and oncological pharmacy.Hospital Clin Pharm2014;
49: 22–28.
